Uses and Limitations of Echocardiography in Neonatal Intensive Care Units

1. Gruentzig AR Senning A Siegenthaler WE. Nonoperative dilatation of coronary artery stenosis: percutaneous transluminal coronary angioplasty. N Engl J Med 1979;301:61

2. Roubin G.S. Status of percutaneous transluminal coronary angioplasty. Curr Probl Cardiol 1990;723–829

3. Leimgruber PP Roubin GS Hollman J , et al. Restenosis after successful coronary angioplasty in patients with single vessel disease. Circulation 1986;73:710–717

4. Serruys PW Luijiten HE Beatt KJ , et al. Incidence of restenosis after successful coronary angioplasty: a time-related phenomenon. A quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months. Circulation 1988;77:361–371

5. Talley JD Hurst JW King SB III , et al. Clinical outcome 5 years after attempted percutaneous transluminal coronary angioplasty in 427 patients. Circulation 1988;77:820–829

6. Roubin GS Sutor C Lembo NJ , et al. Prognosis after multiple vessel angioplasty (PTCA) in patients with coronary artery disease. Circulation 1987;7:465

7. Gravanis MB. The enigma of restenosis after percutaneous transluminal coronary angioplasty. Am J Cardiovasc Pathol 1988;2:1–5

8. Waller BF Pinkerton CA. “Cutters, scoopers, shavers, and scrapers”—the importance of atherectomy devices and clinical relevance of tissue removed. J Am Coll Cardiol 1987;9:1019–1023

9. Waller BF Pinkerton CA Orr CM , et al. Morphologic observations late (<30 days) after clinically successful coronary balloon angioplasty: an analysis of 20 necropsy patients and review of 41 necropsy patients with coronary angioplasty restenosis. Circulation 1991:83(suppl II):II-28-II-41

10. Waller BF. Pathology of coronary balloon angioplasty and related topics. In: Topol EJ , ed. Textbook of interventional cardiology. Philadelphia: WB Saunders, 1990;395–451

11. Faxon DP Weber VJ Haudenschild CC , et al. Acute effects of transluminal angioplasty in three experimental models of atherosclerosis. Arteriosclerosis 1982;2:125–133

12. Faxon DP Sanborn TA Weber VJ , et al. Restenosis following transluminal angioplasty in experimental atherosclerosis. Arteriosclerosis 1984;4:189–195

13. Holmes DR Jr Vlietstra RE Smith HC , et al. Restenosis after percutaneous transluminal coronary angioplasty (PTCA): a report from the PTCA Registry of the National Heart, Lung and Blood Institute. Am J Cardiol 1984;53:77C–81C

14. Halon DA Merdler A Shefer A , et al. Identifying patients at high risk for restenosis after percutaneous transluminal coronary angioplasty for unstable angina pectoris. Am J Cardiol 1989;64:289–293

15. Bertrand ME Lablanche JM Fourrier JL , et al. Relation to restenosis after percutaneous transluminal coronary angioplasty to vasomotion of the dilated coronary arterial segment. Am J Cardiol 1989;63:277–281

16. Leimgruber PP Roubin GS Hollman J , et al. Restenosis after successful coronary angioplasty in patients with single-vessel disease. Circulation 1986;73:710–717

17. Badimon L Badimon JJ Galvez A , et al. Influence of arterial wall damage and wall shear rate on platelet deposition. Ex vivo study in swine model. Arteriosclerosis 1986;6:312–320

18. Adams PC Fuster V Badimon L , et al. Platelet/vessel wall interaction, rheologic factors and thrombogenic substrate in acute coronary syndromes: preventative strategies. Am J Cardiol 1987;60(suppl 6):96–166

19. Waller BF. Early and late morphologic changes in human coronary arteries after percutaneous transluminal coronary angioplasty. Clin Cardiol 1983;6:363–372

20. Waller BF Dillon JC Cowley MH. Plaque hematoma and coronary dissection with percutaneous transluminal angioplasty (PTCA) of severely stenotic lesions. Morphologic coronary observations in 5 men within 30 days of PTCA (abstract). Circulation 1983;68(suppl III):III–144

21. Lundergan C Feogh ML Vargas R , et al. Inhibition of myointimal proliferation of the rat carotid by the peptides, angiopeptin and BLM 23034. Atherosclerosis 1989;80:49

22. Kohchi K Takebayashi S Block PC , et al. Arterial changes after percutaneous coronary angioplasty: results at autopsy. J Am Coll Cardiol 1987;10:592–599

23. Colavita PG Ideker RE Reimer KA , et al. The spectrum of pathology associated with percutaneous transluminal coronary angioplasty during acute myocardial infarction. J Am Coll Cardiol 1986;8:855–860

24. Farb A Virmani R Atkinson JB Kolodgie FD. Plaque morphology and pathologic changes in arteries from patients dying after coronary balloon angioplasty. J Am Coll Cardiol 1990;16:1421–1429

25. Austin GE Ratliff NB Hollman J , et al. Intimal proliferation of smooth muscle cells as an explanation for recurrent coronary artery stenosis after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1985;6:369–375

26. Liu MW Roubin GS King SB. Restenosis after coronary angioplasty: potential biologic determinants and role of intimal hyperplasia. Circulation 1989;79:1374–1387

27. O'Hara T Nanto S Asada S , et al. Ultrastructural study of proliferating and migrating smooth muscle cells at the site of percutaneous transluminal coronary angioplasty as an explanation for restenosis (abstract). Circulation 1988;78(suppl II):II–290

28. Gravanis MB Roubin GS. Histopathologic phenomena at the site of percutaneous transluminal coronary angioplasty. Hum Pathol 1989;20:477

29. Giraldo AA Esposo OM Meis JM. Intimal hyperplasia as a cause of restenosis after percutaneous transluminal coronary angioplasty. Arch Pathol Lab Med 1985;109:173

30. Steele PM Cheseboro JH Stanson AW , et al. Balloon angioplasty: natural history of the pathophysiological response to injury in a pig model. Circ Res 1985;57:105

31. Karas SP Gravanis MB Robinson KA , et al. Comparison of the response to coronary artery balloon injury and stenting in swine: an animal model of restenosis. Circulation 1990;82(suppl III):III–497

32. Schwartz RS Murphy JG Edwards WD , et al. Restenosis after balloon angioplasty: a practical proliferative model in porcine coronary arteries. Circulation 1990;82:2190

33. Waller BF Pinkerton CA Orr CM , et al. Restenosis 1-24 months after clinically coronary balloon angioplasty: a necropsy study of 20 patients. J Am Coll Cardiol 1991;17:58B–70B

34. Nobuyoshi M Takeshi K Nosaka H , et al. Restenosis after successful percutaneous transluminal coronary angioplasty: serial angiographic follow-up of 229 patients. J Am Coll Cardiol 1988;12:616–623

35. Serruys PW Luijten HE Beatt KJ , et al. Incidence of restenosis after successful coronary angioplasty: a time related phenomenon. A quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months. Circulation 1988;77:361–371

36. Fischell TA Derby G Tse TM Stadius ML. Coronary artery vasoconstriction routinely occurs after percutaneous transluminal coronary angioplasty. A quantitative arteriographic analysis. Circulation 1988;78:1323–1334

37. Rensing BJ Hermans WR Strauss BH Serruys PW. Regional differences in elastic recoil after percutaneous transluminal coronary angioplasty: a quantitative angiographic study. J Am Coll Cardiol 1991;17:34B–38B

38. Goldberg RK Kleiman NS Minor ST , et al. Comparison of quantitative coronary arteriography to visual estimates of lesion severity pre and post PTCA. Am Heart J 1990;119:178–184

39. Brown BG Bolson EL Dodge HT. Percutaneous transluminal coronary angioplasty and subsequent restenosis: quantitative and qualitative methodology for their assessment. Am J Cardiol 1987;60:34B–38B

40. Bengtson JR Sheikh KH Aboul-Enein H , et al. Exercise echo-cardiography is a valuable adjunct to treadmill testing for detection of restenosis after coronary angioplasty (abstract). J Am Coll Cardiol 1990;15(suppl A):52A

41. Rowland AJ Rdzanek S Beauchamp GD , et al. Exercise echocardiography correctly predicts restenosis in patients undergoing emergent PTCA or non-Q wave myocardial infarction (abstract). J Am Coll Cardiol 1990;15(suppl A):52A

42. Picano E Pirelli S Marzilli M , et al. Usefulness of high-dose dipyridamole echocardiography test in coronary angioplasty. Circulation 1989;80:807–815

43. Klein LW Rosenblum J. Restenosis after successful percutaneous transluminal coronary angioplasty. Prog Cardiovasc Dis 1990;32: 365–382

44. Goldberg RK Kleiman NS Minor SR , et al. Comparison of quantitative coronary angiography to visual estimates of lesion severity pre and post PTCA. Am Heart J 1990;199:178–184

45. Mancini JGB. Quantitative coronary arteriographic methods in the interventional catheterization laboratory: an update and perspective. J Am Coll Cardiol 1991;17:23B–33B

46. Califf RM Fortin DF Frid DJ , et al. Restenosis after coronary angioplasty: an overview. J Am Coll Cardiol 1991;17:2B–13B

47. Leimgruber PP Roubin GS Hollman J , et al. Restenosis after successful coronary angioplasty in patients with single-vessel disease. Circulation 1986;73:710–717

48. Rensing BJ Hermans WR Strauss BH Serreys PW. Regional differences in elastic recoil after percutaneous transluminal coronary angioplasty. A quantitative angiographic study. J Am Coll Cardiol 1991;17:34B–38B

49. Beatt KJ Luyten HE DeFeyeter PJ , et al. Change in diameter of coronary artery segments adjacent to stenosis after percutaneous transluminal coronary angioplasty: failure of percent diameter stenosis measurement to reflect morphologic changes induced by balloon dilatation. J Am Coll Cardiol 1988;12:315–323

50. El-Tamimi H Davies GJ Hackett D , et al. Very early prediction of restenosis after successful coronary angioplasty: anatomic and functional assessment. J Am Coll Cardiol 1990;15:529–564

51. O'Keefe JH Lapeyre AC Holmes DR Gibbons RJ. Usefulness of early radionuclide angiography for identifying low-risk patients for late restenosis after percutaneous transluminal coronary angioplasty. Am J Cardiol 1988;61:51–54

52. Wijns W Serruys PW Reiber JHC , et al. Early detection of restenosis after successful percutaneous transluminal coronary angioplasty by exercise-redistribution thallium scintigraphy. Am J Cardiol 1985;55:357–361

53. Hardoff R Shefer A Gips S , et al. Predicting late restenosis after coronary angioplasty by very early (12 to 24h) thallium-201 scintigraphy: implications with regard to mechanisms of late coronary restenosis. J Am Coll Cardiol 1990;15:1486–1492

54. Jain A Mahmarian JJ Boges-Neto S , et al. Clinical significance of perfusion defects by thallium-201 single photon emission tomography following oral dipyridamole early after coronary angioplasty. J Am Coll Cardiol 1988;11:970–976

55. Popma JJ Ran den Berg EK Dehmer GJ. Long-term outcome of patients with asymptomatic restenosis after percutaneous coronary angioplasty. Am J Cardiol 1988;62:1298–1299

56. Margolis JR Chen C Glemser E. Restenosis after PTCA is increased in diabetic patients (abstract). Eur Heart J 1989;10(suppl III):III–5

57. Bergelson BA Jacobs AK Small DM. Lipoproteins predict restenosis after PTCA (abstract). Circulation 1989;80(suppl II):II–65

58. Austin GE Hollman J Lynn MJ Meier B. Serum lipoprotein levels fail to predict postangioplasty recurrent coronary artery stenosis. Cleve Clin J Med 1989;56:509–514

59. Galan KM Deligonul L Kern MJ , et al. Increased frequency of restenosis in patients continuing to smoke cigarettes after percutaneous transluminal coronary angioplasty. Am J Cardiol 1988;61:260–263

60. Califf RM Ohman EM Frid DJ , et al. Restenosis: the clinical issues. In: Topol EJ , ed. Interventional cardiology. Philadelphia: WB Saunders, 1989: 363–394

61. Hollman J Badhwar K Beck GJ , et al. Risk factors for recurrent stenosis following successful coronary angioplasty. Cleve Clin J Med 1989;56:517–523

62. Arora R Konrad K Badhwar K Hollman J. Restenosis after transluminal coronanary angioplasty: a risk factor analysis. Cath Cardiovasc Diagn 1990;19:17–22

63. Pepine CJ Hirshfeld JW Macdonald RG , et al. A controlled trial of corticosteroids to prevent restenosis after coronary angioplasty. Circulation 1990;81:1753–1761

64. Liu MW Roubin GS King SB III. Does an optimal luminal result after PTCA reduce restenosis? Circulation 1989;80:63

65. Ellis SG Roubin GS King SB III , et al. Importance of stenosis morphology in the estimation of restenosis risk after elective coronary angioplasty. J Am Coll Cardiol 1989;63:30–34

66. Quigley PJ Hlatky MA Hinohara T , et al. Repeat percutaneous transluminal coronary angioplasty and predictors of recurrent restenosis. Am J Cardiol 1989;63:409–413

67. Black AJ Anderson HV Roubin GS. Repeat coronary angioplasty: correlates of a second restenosis. J Am Coll Cardiol 1988;11: 714–718

68. Roubin GS Redd D Leimgruber P , et al. Restenosis after multilesion and multivessel coronary angioplasty (PTCA) (abstract). J Am Coll Cardiol 1986;7:22

69. Botman CJ El Gammal M El Deeb F , et al. Percutaneous transluminal coronary angioplasty more than twice for the same coronary lesion. Eur Heart J 1989;10(suppl H):112–116

70. Deligonul U Vandormael M Kern MJ. Repeat coronary angioplasty for restenosis: results and predictors of follow-up clinical events. Am Heart J 1989;117:997–1002

71. Teirstein PS Hoover CA Ligon RW , et al. Repeat coronary angioplasty: efficacy of a third angioplasty for a second restenosis. J Am Coll Cardiol 1989;13:291–296

72. Hinohara T Rowe M Sipperly ME , et al. Restenosis following directional coronary atherectomy of native coronary arteries (abstract). J Am Coll Cardiol 1990;15(suppl A):196A

73. Stack RS Phillips HR Quigley PJ , et al. Multicenter registry of a coronary atherectomy using the transluminal extraction-endarteretomy catheter (abstract). J Am Coll Cardiol 1990;15(suppl A):196A

74. Niazi KA Brodsky M Friedman HZ , et al. Restenosis after successful mechanical rotary atherectomy with the Auth rotoblator (abstract). J Am Coll Cardiol 1990;15:57

75. Hinohara T Simpson J Phillips HR Stack R. Transluminal intracoronary reperfusion catheter: a device to maintain coronary perfusion between failed coronary angioplasty and emergency bypass surgery. J Am Coll Cardiol 1988;11:977–982

76. Quigley PJ Kereiakes DJ Abbotsmith CW , et al. Prolonged autoperfusion angioplasty: immediate clinical outcome and angiographic follow-up. J Am Coll Cardiol 1989;13(suppl A):155A

77. Serruys PW Beatt KJ Bertrand M , On behalf of the Working Group of Endoluminal Coronary Artery Prostheses. Restenosis rate after coronary stent implantation: angiographic assessment of the initial series (abstract). Circulation 1989;80(suppl II):II–690

78. Ellis SG Savage MP Leon MB , et al. Intracoronary stenting to prevent restenosis: preliminary results of a multicenter study using the Palmaz-Schatz stent suggest benefit in selected high risk patients (abstract). J Am Coll Cardiol 1990;15(suppl A):118A

79. Block PC. Histological and ultrastructural studies in animals. In: Proceedings of the Workshop on Percutaneous Transluminal Coronary Angioplasty. Washington, DC: DHEW Publication No. (NIH) 80-2030, 1980:155–159

80. Faxon DP Weber VJ Haudenschild C , et al. Acute effects of transluminal angioplasty in three experimental models of atherosclerosis. Arteriosclerosis 1982;2: 125–133

81. Schatz RA Bain DS Leon M , et al. Restenosis after placement of Palmaz Schatz stents in native coronary arteries: initial results of multicenter experience

82. Muller DWM Ellis SG. Advances in angioplasty: endovascular stents. Coronary Artery Disease 1990;1:413–414

83. Litvak F Margolis J Eigler N , et al. Percutaneous excimer laser coronary and angioplasty: results of the first 110 procedures (abstract). J Am Coll Cardiol 1990;15(suppl A):25A

84. Ferguson JJ Dear WE Leatherman LL , et al. A multicenter trial of laser balloon angioplasty for abrupt closure following PTCA (abstract). J Am Coll Cardiol 1990;15(suppl A):25A

85. Karsch KR Hasse KK Noelker W , et al. Percutaneous coronary excimer laser angioplasty in patients with stable and unstable angina pectoris: acute results and incidence of restenosis during 6-month follow-up. Circulation 1990;81: 849–859

86. Hanson SR Pareti FI Ruggeri ZM , et al. Effects of monoclonal antibodies against the platelet glycoprotein IIb/IIIa complex on thrombosis and hemostasis in the baboon. J Clin Invest 1988;81:149–158

87. Bates ER McGillem MH Mickelson JK , et al. A monoclonal antibody to the platelet receptor (GP11b/IIIa (7E3) prevents acute thrombosis in a canine model of coronary angioplasty (abstract). Circulation 1988;78(suppl):II–289

88. Heras M Chesebro JH Penny WJ , et al. Effects of thrombin inhibitiion on the development of acute platelet-thrombus deposition during angioplasty in pigs. Heparin versus recombinant hirudin, a specific thrombin inhibitor. Circulation 1989;79:657–665

89. Hanson SR Harker LA. Interruption of acute platelet-dependent thrombosis by the synthetic antithrombin D-phenylalanyl-L-prolyl-L-arginyl chloromethyl ketone. Proc Natl Acad Sci USA 1988;85:3184–3188

90. Fairbanks KP Barbu VD Witte LD , et al. Effects of mevinolin and mevalonate on cell growth in several transformed cell lines. J Cell Physiol 1986;127:216–222

91. Ellis SG Roubin GS Wilentz J , et al. Effect of 18-to-24-hour heparin administration for prevention of restenosis after uncomplicated coronary angioplasty. Am Heart J 1989;117:777–782

92. Corcos T David PR Val PG , et al. Failure of diltiazem to prevent restenosis after percutaneous transluminal coronary angioplasty. Am Heart J 1985;109:926–931

93. Whitworth HB Roubin GS Hollman J , et al. Effect of nifedipine on recurrent stenosis after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1986;8:1271–1276

94. Grigg LE Kay TWH Valentine PA , et al. Determinants of restenosis and lack of effect of dietary supplementation with eicosapentaenoic acid on the incidence of coronary artery restenosis after angioplasty. J Am Coll Cardiol 1989;13:665–672

95. Hollman J Konrad K Raymond R , et al. Lipid lowering for the prevention of recurrent stenosis following coronary angioplasty (abstract). Circulation 1989;80(suppl II):II–65